These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1918168)

  • 1. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
    Leung S; Miyamoto NG
    J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the human T-cell-specific tyrosine kinase YT16 (lck) message in leukemic T-cell lines.
    Koga Y; Kimura N; Minowada J; Mak TW
    Cancer Res; 1988 Feb; 48(4):856-9. PubMed ID: 3257410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
    Rouer E; Dreyfus F; Melle J; Benarous R
    Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of an ETS-binding element for transcription of the human lck type I promoter.
    Leung S; McCracken S; Ghysdael J; Miyamoto NG
    Oncogene; 1993 Apr; 8(4):989-97. PubMed ID: 8455950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma.
    McCracken S; Kim CS; Xu Y; Minden M; Miyamoto NG
    Oncogene; 1997 Dec; 15(24):2929-37. PubMed ID: 9416836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of alternatively spliced lck transcripts from the proximal promoter in colorectal cancer derived cell lines.
    Mayer K; Ballhausen WG
    Anticancer Res; 1996; 16(4A):1733-7. PubMed ID: 8712692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of two lck transcripts directed from the distinct promoters in HTLV-I+ and HTLV-I- T-cells.
    Nakamura K; Koga Y; Yoshida H; Kimura G; Nomoto K
    Int J Cancer; 1991 Jul; 48(5):789-93. PubMed ID: 1712760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines.
    Koga Y; Oh-Hori N; Sato H; Yamamoto N; Kimura G; Nomoto K
    J Immunol; 1989 Jun; 142(12):4493-9. PubMed ID: 2786034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
    Rouer E; Benarous R
    Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
    Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
    J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
    Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
    J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional dissection of the murine lck distal promoter.
    Wildin RS; Wang HU; Forbush KA; Perlmutter RM
    J Immunol; 1995 Aug; 155(3):1286-95. PubMed ID: 7636195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the two promoters of the human lck gene: differential accumulation of two classes of lck transcripts in T cells.
    Takadera T; Leung S; Gernone A; Koga Y; Takihara Y; Miyamoto NG; Mak TW
    Mol Cell Biol; 1989 May; 9(5):2173-80. PubMed ID: 2787474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lck tyrosine kinase is important for activation of the CD11a/CD18-integrins in human T lymphocytes.
    Fagerholm S; Hilden TJ; Gahmberg CG
    Eur J Immunol; 2002 Jun; 32(6):1670-8. PubMed ID: 12115650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of integrated adenovirus E1A and E1B genes in transformed human cells by phorbol ester tumor promoters.
    Carter T; James C; Chan E; Greene B
    Cancer Res; 1987 Feb; 47(3):803-8. PubMed ID: 2948635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
    Rouer E; Brule F; Benarous R
    Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and expression of lck transcripts in human lymphoid cells.
    Perlmutter RM; Marth JD; Lewis DB; Peet R; Ziegler SF; Wilson CB
    J Cell Biochem; 1988 Oct; 38(2):117-26. PubMed ID: 3265417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.